615-16-7 | 2-Hydroxybenzimidazole

Packsize	Purity	Availability	Price	Discounted Price
10g	99%	in stock	$8.00	$5.00
25g	99%	in stock	$15.00	$10.00
100g	99%	in stock	$29.00	$20.00

Description

• Catalog Number: AI53706
• Chemical Name: 2-Hydroxybenzimidazole
• CAS Number: 615-16-7
• Molecular Formula: C7H6N2O
• Molecular Weight: 134.13534
• MDL Number: MFCD00127894
• SMILES: O=c1[nH]c2c([nH]1)cccc2

Computed Properties

• Complexity: 142
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 10
• Hydrogen Bond Acceptor Count: 1
• Hydrogen Bond Donor Count: 2
• XLogP3: 1.1

Upstream Synthesis Route

2-Hydroxybenzimidazole, also known as salicylimidazole, is a versatile compound widely utilized in chemical synthesis. Its unique structure and properties make it a valuable component in various reactions and processes within the field of chemistry.In chemical synthesis, 2-Hydroxybenzimidazole serves as a crucial building block for the creation of many organic compounds. It can participate in condensation reactions to form heterocyclic ring structures, lending its aromatic character to the final product. The hydroxyl group presents in 2-Hydroxybenzimidazole enables it to engage in hydrogen bonding interactions, leading to the formation of complex molecular architectures with enhanced properties.Furthermore, 2-Hydroxybenzimidazole is often employed as a precursor in the synthesis of pharmaceutical compounds, agrochemicals, and specialty chemicals. Its presence in the synthesis pathway can dictate the stereochemistry and functional group arrangements in the final product, influencing its biological or chemical activity. By incorporating 2-Hydroxybenzimidazole into the synthesis route, chemists can achieve targeted modifications and optimize the desired properties of the end product.Overall, the application of 2-Hydroxybenzimidazole in chemical synthesis extends beyond a mere reagent; it acts as a strategic intermediate that imparts specific characteristics and functionalities to diverse molecules, thereby expanding the scope of synthesis possibilities for chemists across various disciplines.

Literature

• Aza-oxindole synthesis via base promoted Truce-Smiles rearrangement.

  Chemical communications (Cambridge, England) 20121118

• 1-Octyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20120501

• Aza-oxindole synthesis by oxidative coupling of C(sp2)-H and C(sp3)-H centers.

  Chemical communications (Cambridge, England) 20120325

• 1,3-Dibenzyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20111201

• 5-Chloro-1-nonyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20111201

• 1-Decyl-6-nitro-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20111101

• Expanding the repertoire of natural product-inspired ring pairs for molecular recognition of DNA.

  Organic letters 20111021

• Synthesis and Diels-Alder cycloadditions of exo-imidazolidin-2-one dienes.

  The Journal of organic chemistry 20111007

• Receptor-based QSAR study for a series of 3,3-disubstituted-5-aryl oxindoles and 6-aryl benzimidazol-2-ones derivatives as progesterone receptor inhibitors.

  SAR and QSAR in environmental research 20111001

• 1-Benzyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20110701

• Potassium hydroxide/dimethyl sulfoxide promoted intramolecular cyclization for the synthesis of benzimidazol-2-ones.

  Organic letters 20110603

• 1,3-Bis(prop-2-yn-yl)-1H-1,3-benzimid-azol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20110501

• 1-Nonyl-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20110201

• 1,3-Bis[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20110201

• A classification study of respiratory Syncytial Virus (RSV) inhibitors by variable selection with random forest.

  International journal of molecular sciences 20110101

• An inducible expression system of the calcium-activated potassium channel 4 to study the differential impact on embryonic stem cells.

  Stem cells international 20110101

• Isolation and characterization of Pseudomonas sp. CBW capable of degrading carbendazim.

  Biodegradation 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Biodegradation of carbendazim by a novel actinobacterium Rhodococcus jialingiae djl-6-2.

  Chemosphere 20101001

• Computational thermochemistry of six ureas, imidazolidin-2-one, N,N'-trimethyleneurea, benzimidazolinone, parabanic acid, barbital (5,5'-diethylbarbituric acid), and 3,4,4'-trichlorocarbanilide, with an extension to related compounds.

  The journal of physical chemistry. A 20100902

• Inhibition of protein kinase C-driven nuclear factor-kappaB activation: synthesis, structure-activity relationship, and pharmacological profiling of pathway specific benzimidazole probe molecules.

  Journal of medicinal chemistry 20100624

• Slow binding-tight binding interaction between benzimidazol-2-one inhibitors and HIV-1 reverse transcriptase containing the lysine 103 to asparagine mutation.

  Antiviral research 20100601

• 1-Isopropenyl-1H-1,3-benzimidazol-2(3H)-one.

  Acta crystallographica. Section E, Structure reports online 20100601

• Identification of potent, highly constrained CGRP receptor antagonists.

  Bioorganic & medicinal chemistry letters 20100415

• 1-{[(Cyclo-hexyl-oxy)carbon-yl]-oxy}ethyl 3-{[2'-(2-ethyl-2H-tetra-zol-5-yl)biphenyl-4-yl]meth-yl}-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxyl-ate.

  Acta crystallographica. Section E, Structure reports online 20100401

• Rapid access towards follow-up NOP receptor agonists using a knowledge based approach.

  Bioorganic & medicinal chemistry letters 20091115

• 1,3-Bis(hydroxy-meth-yl)benzimidazolin-2-one.

  Acta crystallographica. Section E, Structure reports online 20091101

• 1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.

  Journal of medicinal chemistry 20090924

• Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.

  Bioorganic & medicinal chemistry 20090815

• The discovery of highly potent CGRP receptor antagonists.

  Bioorganic & medicinal chemistry letters 20090101

• Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties.

  Bioorganic & medicinal chemistry 20080315

• Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety.

  Bioorganic & medicinal chemistry letters 20070901

• Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activity.

  Bioorganic & medicinal chemistry letters 20070815

• DFT studies of the structure and vibrational assignments of 4-hydroxy quinazoline and 2-hydroxy benzimidazole.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070401

• Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties.

  Bioorganic & medicinal chemistry 20070215

• Benzofused tricycles based on 2-quinoxalinol.

  Journal of combinatorial chemistry 20070101

• Respiratory syncytial virus fusion inhibitors. Part 3: Water-soluble benzimidazol-2-one derivatives with antiviral activity in vivo.

  Bioorganic & medicinal chemistry letters 20060301

• Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.

  Journal of medicinal chemistry 20050505

• Activation of human IK and SK Ca2+ -activated K+ channels by NS309 (6,7-dichloro-1H-indole-2,3-dione 3-oxime).

  Biochimica et biophysica acta 20041011

• Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives.

  Bioorganic & medicinal chemistry letters 20040308

• A theoretical study of substituent effects on tautomerism of 2-hydroxybenzimidazoles.

  Journal of molecular modeling 20031201

• Imidazopyridine/Pyrrole and hydroxybenzimidazole/pyrrole pairs for DNA minor groove recognition.

  Journal of the American Chemical Society 20030514

• Preparation of oxime dual NK(1)/NK(2) antagonists with reduced NK(3) affinity.

  Bioorganic & medicinal chemistry letters 20020902

• New generation dopaminergic agents. Part 8: heterocyclic bioisosteres that exploit the 7-OH-2-(aminomethyl)chroman D(2) template.

  Bioorganic & medicinal chemistry letters 20020211